[go: up one dir, main page]

YU48396A - Zviterjonski oblici trovafloksacina, postupak za njihovo dobijanje i njihove farmaceutske kompozicije - Google Patents

Zviterjonski oblici trovafloksacina, postupak za njihovo dobijanje i njihove farmaceutske kompozicije

Info

Publication number
YU48396A
YU48396A YU48396A YU48396A YU48396A YU 48396 A YU48396 A YU 48396A YU 48396 A YU48396 A YU 48396A YU 48396 A YU48396 A YU 48396A YU 48396 A YU48396 A YU 48396A
Authority
YU
Yugoslavia
Prior art keywords
preparation
pharmaceutical compositions
trovaphloxacine
zwitterionic forms
zwitterionic
Prior art date
Application number
YU48396A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
John Meldrum Allen Douglas
Bruning Joseph David
Norris Timothy
Original Assignee
Pfizer Inc Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc Delaware filed Critical Pfizer Inc Delaware
Publication of YU48396A publication Critical patent/YU48396A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Physical Water Treatments (AREA)
  • Processing Of Solid Wastes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
YU48396A 1995-08-29 1996-08-28 Zviterjonski oblici trovafloksacina, postupak za njihovo dobijanje i njihove farmaceutske kompozicije YU48396A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US297595P 1995-08-29 1995-08-29

Publications (1)

Publication Number Publication Date
YU48396A true YU48396A (sh) 1998-12-23

Family

ID=21703460

Family Applications (1)

Application Number Title Priority Date Filing Date
YU48396A YU48396A (sh) 1995-08-29 1996-08-28 Zviterjonski oblici trovafloksacina, postupak za njihovo dobijanje i njihove farmaceutske kompozicije

Country Status (30)

Country Link
EP (1) EP0850060A1 (fr)
JP (1) JP3188476B2 (fr)
KR (1) KR100343909B1 (fr)
CN (1) CN1190889A (fr)
AP (1) AP636A (fr)
AR (1) AR003985A1 (fr)
AU (1) AU704115B2 (fr)
BR (1) BR9609998A (fr)
CA (1) CA2229786C (fr)
CO (1) CO4480739A1 (fr)
CZ (1) CZ56698A3 (fr)
DZ (1) DZ2087A1 (fr)
GT (1) GT199600072A (fr)
HR (1) HRP960395B1 (fr)
HU (1) HUP9900170A3 (fr)
IL (1) IL122651A (fr)
MA (1) MA23966A1 (fr)
MY (1) MY113874A (fr)
NO (1) NO309814B1 (fr)
NZ (1) NZ312199A (fr)
OA (1) OA10669A (fr)
PE (1) PE12598A1 (fr)
PL (1) PL325170A1 (fr)
RU (1) RU2144921C1 (fr)
SK (1) SK23898A3 (fr)
TN (1) TNSN96109A1 (fr)
TR (1) TR199800339T1 (fr)
WO (1) WO1997007800A1 (fr)
YU (1) YU48396A (fr)
ZA (1) ZA967282B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
US6239141B1 (en) 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS274601B2 (en) * 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
NZ232091A (en) * 1989-01-16 1990-12-21 Bellon Labor Sa Roger 7-fluoro-8-(piperazin-1-yl)-4-oxo-1,4-dihydro-benzo(b)(1,8)naphthyridine-3-carboxylic acid derivatives, preparation and pharmaceutical compositions thereof
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
ES2178701T3 (es) 1995-06-15 2003-01-01 Pfizer Procedimiento para preparar derivados del acido azabiciclo naftriridina carboxilico que comprenden un dipeptido.

Also Published As

Publication number Publication date
JP3188476B2 (ja) 2001-07-16
HRP960395A2 (en) 1998-06-30
CA2229786C (fr) 2002-02-19
CO4480739A1 (es) 1997-07-09
IL122651A (en) 2000-02-17
ZA967282B (en) 1998-03-02
NZ312199A (en) 1999-06-29
BR9609998A (pt) 1999-07-06
AU6367696A (en) 1997-03-19
KR100343909B1 (ko) 2003-04-10
CN1190889A (zh) 1998-08-19
DZ2087A1 (fr) 2002-07-22
IL122651A0 (en) 1998-08-16
MX9801664A (es) 1998-08-30
CZ56698A3 (cs) 1999-02-17
SK23898A3 (en) 1999-05-07
HUP9900170A2 (hu) 1999-05-28
TNSN96109A1 (fr) 2005-03-15
HRP960395B1 (en) 2001-12-31
HUP9900170A3 (en) 1999-11-29
AU704115B2 (en) 1999-04-15
MA23966A1 (fr) 1997-04-01
JPH10511692A (ja) 1998-11-10
GT199600072A (es) 1998-02-14
CA2229786A1 (fr) 1997-03-06
AP636A (en) 1998-04-09
EP0850060A1 (fr) 1998-07-01
AR003985A1 (es) 1998-09-30
NO309814B1 (no) 2001-04-02
PE12598A1 (es) 1998-03-20
OA10669A (en) 2000-11-06
NO980862D0 (no) 1998-02-27
KR19990044232A (ko) 1999-06-25
RU2144921C1 (ru) 2000-01-27
TR199800339T1 (xx) 1998-06-22
AP9600853A0 (en) 1996-10-31
WO1997007800A1 (fr) 1997-03-06
PL325170A1 (en) 1998-07-06
MY113874A (en) 2002-06-29
NO980862L (no) 1998-02-27

Similar Documents

Publication Publication Date Title
YU16501A (sh) 4-karboksiamido-2-supstituisani-1,2,3,4-tetrahidrohinolini kao inhibitori cetp
YU18101A (sh) 4-amino supstituisani-2-supstituisani-1,2,3,4- tetrahidrohinolini kao inhibitori cetp
DE69634045D1 (de) Antithrombotische diamine
HN1998000074A (es) Derivados de macrolidos c-4 sustituidos
ES2018111A6 (es) Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
CY1111693T1 (el) Αντιιικοι παραγοντες
AR038955A1 (es) Compuestos de pirimidinona y piridona sustituidos y metodos para su uso
BR0111263A (pt) Derivados de 2-aminocarbonil-9h-purina
YU56995A (sh) Soli derivata indola
FI20115753L (fi) Farmaseuttisia koostumuksia IL-6:n tuoton aiheuttamien sairauksien hoitoon
BR0112395A (pt) Derivados de benzotiazol
EA200501098A1 (ru) Антибактериальные агенты
UA44254C2 (uk) Похідні 4-(заміщеного феніламіно)хіназоліну, спосіб їх одержання, спосіб лікування і фармацевтична композиція
NO2006002I2 (no) Posakonazol eventuelt i form av en ester og/eller et farmasøytisk akseptabelt salt derav.
HUP0401538A2 (hu) Új, helyettesített aminometilcsoportot tartalmazó N-(arilszulfonil)-béta-aminosav-származékok, előállításukra alkalmas eljárás és a vegyületeket tartalmazó gyógyászati készítmények
DK0462812T3 (da) Pyranderivater som inhibitorer af 5-lipoxygenase
CO4970821A1 (es) Nuevos macrolidos
YU33401A (sh) 13-točlani azalidi i njihova primena kao antibiotičkih sredstava
HRP20080192T3 (hr) Meldonijeve soli, postupci za njihovu pripravu i farmaceutski sastav na njihovoj osnovi
AR005597A1 (es) Derivados de benzoxazina , composiciones farmaceuticas para el tratamiento de infecciones bacterianas, y metodo para la preparacion de dichos derivados.
DK1057828T3 (da) Orale trovafloxacin-suspensioner
YU48396A (sh) Zviterjonski oblici trovafloksacina, postupak za njihovo dobijanje i njihove farmaceutske kompozicije
EA200400214A1 (ru) Азитромицин в виде разовой дозы
YU42098A (sh) Upotreba olanzapina
EA200001029A1 (ru) Производные гигромицина